IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 226-250 out of 1375.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>

Public Release: 24-Jun-2015
Nature Communications
Eavesdropping on the body: New device tracks chemical signals within cells
Biomedical engineers at the University of Toronto have invented a new device that more quickly and accurately 'listens in' on the chemical messages that tell our cells how to multiply. The tool improves our understanding of how cancerous growth begins, and could identify new targets for cancer medications.

Contact: RJ Taylor
rj.taylor@utoronto.ca
416-978-4498
University of Toronto Faculty of Applied Science & Engineering

Public Release: 24-Jun-2015
Eating Behaviors
Eating in the absence of hunger: A recipe for expanding waistline
QUT researcher Dr Stephanie Fay has found that snacking when you're not hungry can cause weight gain as much as overly large portion sizes and energy-rich foods. Her findings have just been published in an international journal.

Contact: Amanda Weaver
amanda.weaver@qut.edu.au
Queensland University of Technology

Public Release: 24-Jun-2015
Nature
Targeting telomeres, the timekeepers of cells, could improve chemotherapy
In an unexpected finding, the Salk Institute and collaborators show how disabling telomere protection during cell division prompts cell death.

Contact: Salk Communications
press@salk.edu
Salk Institute

Public Release: 24-Jun-2015
Tobacco Control
As smoking declines, more are likely to quit
Smokeless tobacco and, more recently, e-cigarettes have been promoted as a harm reduction strategy for smokers who are 'unable or unwilling to quit.' The strategy, embraced by both industry and some public health advocates, is based on the assumption that as smoking declines overall, only those who cannot quit will remain. A new study by researchers at UC San Francisco has found just the opposite.
NIH/National Cancer Institute

Contact: Lisa Potter
lisa.potter@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 24-Jun-2015
Science Translational Medicine
DNA shed from head and neck tumors detected in blood and saliva
On the hunt for better cancer screening tests, Johns Hopkins scientists led a proof of principle study that successfully identified tumor DNA shed into the blood and saliva of 93 patients with head and neck cancer. A report on the findings is published in the June 24 issue of Science Translational Medicine.
Virginia and D.K. Ludwig Fund for Cancer Research, Conrad R. Hilton Foundation, Banyan Gate Foundation, Swim Across America, Sol Goldman Sequencing Facility at Johns Hopkins, NIH/National Cancer Institute

Contact: Vanessa Wasta
wasta@jhmi.edu
410-614-2916
Johns Hopkins Medicine

Public Release: 24-Jun-2015
New England Journal of Medicine
Detroit patients' contributions to national study re-define low-grade brain tumor diagnosis
Sixty-seven patients from the Hermelin Brain Tumor Center at Henry Ford Hospital and their families made important contributions to a national cancer study that proposes a change in how some brain tumors are classified and ultimately treated. Published in the July 25 issue of the New England Journal of Medicine, the study reveals that a tumor's DNA is key to determining if a lower-grade malignant brain tumor may rapidly progress to glioblastoma.

Contact: Krista Hopson Boyer
kboyer1@hfhs.org
313-874-7207
Henry Ford Health System

Public Release: 24-Jun-2015
Nature
Tiny particles in blood useful for early diagnosis of pancreatic cancer
A protein encoded by the gene glypican-1 present on cancer exosomes may be used as part of a potential non-invasive diagnostic and screening tool to detect early pancreatic cancer, potentially at a stage amenable to surgical treatment, according to a study at The University of Texas MD Anderson Cancer Center.

Contact: Ron Gilmore
rlgilmore1@mdanderson.org
713-745-1898
University of Texas M. D. Anderson Cancer Center

Public Release: 23-Jun-2015
Cancer
Current blood cancer drug prices not justified, MD Anderson study finds
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.

Contact: Clayton R. Boldt
crboldt@mdanderson.org
713-792-9518
University of Texas M. D. Anderson Cancer Center

Public Release: 23-Jun-2015
Genome Medicine
New colon cancer culprit found in gut microbiome
Changes in the gut bacteria of colon cancer patients indicate that some virulent bacteria could be linked to the progression of the disease, according to research published in the open-access journal Genome Medicine. The findings could eventually be used to identify a virulence signature in these cancers and help doctors predict how bacterial changes in patients' guts could affect their prognosis.

Contact: Alanna Orpen
alanna.orpen@biomedcentral.com
44-203-192-2054
BioMed Central

Public Release: 23-Jun-2015
Radiology
CT allows nonsurgical management of some lung nodules
People who have nonsolid lung nodules can be safely monitored with annual low-dose computed tomography screening, according to a new study. Researchers said the findings could help spare patients from unnecessary surgery and additional imaging.
National Institutes of Health

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

Public Release: 23-Jun-2015
The American Journal of Surgical Pathology
'Smarter' ordering of breast biomarker tests could save millions in health care dollars
A review of medical records for almost 200 patients with breast cancer suggests that more selective use of biomarker testing for such patients has the potential to save millions of dollars in health care spending without compromising care, according to Johns Hopkins researchers.

Contact: Shawna Williams
shawna@jhmi.edu
410-955-8236
Johns Hopkins Medicine

Public Release: 23-Jun-2015
JAMA
Viagra does something very important -- but it is unlikely to cause melanoma, researchers conclude
A rigorous analysis of more than 20,000 medical records concludes that erectile dysfunction drugs, such as Viagra, are not a cause of melanoma, an often deadly form of skin cancer, despite the higher risk for the disease among users of these drugs.

Contact: David March
david.march@nyumc.org
212-404-3528
NYU Langone Medical Center / New York University School of Medicine

Public Release: 23-Jun-2015
Journal of Adolescent Health
Adolescents uncertain about risks of marijuana, e-cigarettes, Stanford study finds
Teenagers are very familiar with the risks of smoking cigarettes, but are much less sure whether marijuana or e-cigarettes are harmful, according to a new study by researchers at the Stanford University School of Medicine.
NIH/National Cancer Institute

Contact: Erin Digitale
digitale@stanford.edu
650-724-9175
Stanford University Medical Center

Public Release: 23-Jun-2015
Annals of Surgery
Researchers develop new breath test to diagnose esophageal and gastric cancer
Researchers have devised a breath test that can help doctors diagnose the early signs of esophageal and gastric cancer in minutes.
NIHR Imperial Biomedical Research Centre, NIHR-diagnostic Evidence Cooperatives

Contact: Maxine Myers
Maxine.Myers@imperial.ac.uk
44-020-759-46708
Imperial College London

Public Release: 23-Jun-2015
JAMA
Drugs for impotence do not increase risk of melanoma
Using drugs for impotence does not increase the risk of malignant melanoma, researchers from Umeå University in Sweden conclude in a publication in JAMA, a top US medical journal. These results contradict previous research indicating such an association.

Contact: Mattias Grundström Mitz
mattias.mitz@umu.se
46-907-866-465
Umea University

Public Release: 23-Jun-2015
Cancer Science
Smoking may impact survival after a breast cancer diagnosis
Researchers have found that smoking may increase the risk of dying early in premenopausal women with breast cancer.

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley

Public Release: 23-Jun-2015
Nature Genetics
Study identifies multiple genetic changes linked to increased pancreatic cancer risk
In a genome-wide association study believed to be the largest of its kind, Johns Hopkins researchers have uncovered four regions in the human genome where changes may increase the risk of pancreatic cancer.
National Institutes of Health

Contact: Ekaterina Pesheva
epeshev1@jhmi.edu
410-502-9433
Johns Hopkins Medicine

Public Release: 23-Jun-2015
Radiology
Annual low-dose CT screening safe and reliable for identifying pre-cancers
An annual exam using a key imaging technology could spare patients with lung nodules from unnecessary tests and surgery.

Contact: Lucia Lee
newsmedia@mssm.edu
646-605-5940
The Mount Sinai Hospital / Mount Sinai School of Medicine

Public Release: 23-Jun-2015
IEEE SENSORS JOURNAL
Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis
A nanobiosensor for the early diagnosis of certain types of cancer, as well as nervous system diseases such as multiple sclerosis and neuromyelitis optica, was developed by researches in São Paulo State, Brazil. The nanometric sensor is capable of identifying biomarkers of these pathological conditions. An article about the nanobiosensor has just been published as a cover feature by IEEE Sensors Journal.
FAPESP - São Paulo Research Foundation

Contact: Samuel Antenor
samuel@fapesp.br
55-113-838-4381
Fundação de Amparo à Pesquisa do Estado de São Paulo

Public Release: 22-Jun-2015
Journal of the American College of Cardiology
Cardio-oncology services may improve patient care if more widely available
The impact of cancer treatments on cardiovascular health is an important consideration when treating cancer patients, but many hospital training programs have no formal training or services in cardio-oncology and a lack of national guidelines and funding are frequent barriers to establishing such programs, according to a nationwide survey published today in the Journal of the American College of Cardiology.

Contact: Nicole Napoli
nnapoli@acc.org
202-375-6523
American College of Cardiology

Public Release: 22-Jun-2015
Canadian Medical Association Journal
Most women with early-stage breast cancer undergo imaging for metastatic cancer despite guidelines
Most women -- about 86 percent -- with early-stage breast cancer will undergo imaging to determine if the cancer has metastasized, despite international guidelines that recommend against testing, found a study in CMAJ (Canadian Medical Association Journal).
Patient Quality and Safety Committee, Department of Medicine and Division of Medical Oncology, University of Ottawa

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116 x2224
Canadian Medical Association Journal

Public Release: 22-Jun-2015
Oncogene
Stress hormones could undermine breast cancer therapy
Stress hormones often given to patients to treat the side effects of therapy may cause a subset of breast cancers to become treatment-resistant.

Contact: Edyta Zielinska
edyta.zielinska@jefferson.edu
215-955-5291
Thomas Jefferson University

Public Release: 22-Jun-2015
EBioMedicine
A fuse of cardiovascular diseases
A promising biomarker for the severity of age-related white matter changes and endothelial function was evaluated at Hiroshima University, Japan. The researchers at Hiroshima University investigated the association between the telomeric 3'-overhang length of leukocytes and vascular risk, ARWMCs, and endothelial function. They suggested that the telomere G-tail might be a useful marker of endothelial dysfunction, as well as stroke and dementia.
Smoking Research Foundation, Tsuchiya Foundation, Japan Science and Technology Agency, Japan Heart Foundation, Scientific Research on Priority Areas from the Ministry of Education

Contact: Norifumi Miyokawa
pr-research@office.hiroshima-u.ac.jp
Hiroshima University

Public Release: 22-Jun-2015
Journal of Nuclear Medicine
Award-winning agent developed for prostate cancer diagnosis and treatment
Scientists at the German Cancer Research Center have developed an agent called PSMA-617, which is capable of attaching specifically to prostate cancer cells. This agent can be labeled with various radioactive substances. When chemically bound to a weakly radioactive diagnostic radionuclide, it can detect prostate tumors and their metastases in PET scans. If labeled with a strongly radioactive therapeutic radionuclide, PSMA-617 can specifically destroy cancer cells. A first clinical application of this radiopharmaceutical at Heidelberg University Hospital has now delivered promising results.

Contact: Stefanie Seltmann
presse@dkfz.de
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)

Public Release: 22-Jun-2015
International Society of Thrombosis and Hemostasis Meeting
New England Journal of Medicine
Study could reduce unnecessary cancer screening
A large clinical trial led by researchers at The Ottawa Hospital and the University of Ottawa has found that contrary to expectations, a CT scan of the abdomen and pelvis does not improve cancer detection in people with unexplained blood clots in their legs and lungs. The results, published in the June 22nd edition of the New England Journal of Medicine, are expected to improve patient care and reduce screening costs around the world.
Heart and Stroke Foundation of Canada, Ottawa Hospital Foundation

Contact: Lois Ross
loross@ohri.ca
613-737-8899 x73687
Ottawa Hospital Research Institute

Showing releases 226-250 out of 1375.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>

  Search News Releases

     

 

EurekAlert!